Showing results (261-270 of 435) with videos related to
Sort By:
Pageof 44
Biorxiv : the Preprint Server for Biology|December 15, 2025
Deconvolution of Sparse-count RNA Sequencing Data for Tumor Cells Using Embedded Negative Binomial DistributionsMatthew D Montierth, Hao Yan, Liyang Xie, et al.Cancer|October 5, 2017
First-in-human trial of the PI3Kβ-selective inhibitor SAR260301 in patients with advanced solid tumorsPhilippe L Bédard, Michael A Davies, Scott Kopetz, et al.Plos Pathogens|July 14, 2017
Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor developmentRitesh Kumar, Jennifer L Herold, Deborah Schady, et al.JCO Precision Oncology|September 11, 2020
Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal CancerBenny Johnson, Jonathan M Loree, Alexandre A Jacome, et al.Research Square|October 27, 2023
New Insights into Macrophage Polarization and its Prognostic Role in Patients with Colorectal Cancer Liver MetastasisIsha Khanduri, Harufumi Maki, Anuj Verma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive CancerMing Zhao, Stephen Scott, Kurt W Evans, et al.BMC Cancer|October 19, 2019
Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancerShailesh Mahesh Advani, Pragati Shailesh Advani, Derek W Brown, et al.British Journal of Cancer|August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinomaKrittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2018
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With ImmunotherapyChristine M Parseghian, Madhavi Patnana, Priya Bhosale, et al.Cancer|October 4, 2013
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapyAtin Agarwal, George J Chang, Chung-Yuan Hu, et al.Pageof 44